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1  | INTRODUCTION
The pathophysiology of atherosclerotic cardiovascular disease 
(CVD) is only partially understood. Dyslipidemia, such as elevated 
low‐density lipoprotein (LDL) cholesterol and triglycerides or low 
levels of high‐density lipoprotein (HDL) cholesterol, is an estab‐
lished risk factor and plays a crucial role in the development and 
progression of vascular disease, such as CVD and ischemic stroke.1,2 
Serum lipid profiles are frequently evaluated in general clinical 
practice. Among lipid profile parameters, the ratio of triglyceride to 
high‐density lipoprotein cholesterol (TG/HDL) is positively linked to 
insulin resistance, and it has emerged as an independent predictor 
of CVD.3,4
For women, menopause is an additional risk factor due to the 
loss of hormonal protection to traditional risk factors. The reason for 
this is that high TG/HDL ratio is associated with increased athero‐
sclerotic arterial disease and hypertension in premenopausal women 
as well.5 Postmenopausal women are more susceptible to increased 
weight gain and fat redistribution accompanied by marked changes 
in estrogen level.6 Decreased estrogen levels also influence lipid 
metabolism in vascular smooth muscle and the endothelium.7 Thus, 
menopause is characterized by various detrimental metabolic and 
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The ratio of triglyceride to high‐density lipoprotein cholesterol (TG/HDL) is posi‐
tively linked to insulin resistance, and it has emerged as an independent predictor of 
cardiovascular disease. Menopause is characterized by various detrimental metabolic 
and vascular changes that may lead to high TG with low HDL cholesterol and arterial 
stiffness. Several epidemiological studies have reported that high TG/HDL ratio has 
a positive association with arterial stiffness in both adult and adolescent populations; 
it is not known whether TG/HDL ratio is related to brachial‐ankle PWV (baPWV) in 
postmenopausal women. Thus, the authors aimed to investigate the association be‐
tween TG/HDL ratio and arterial stiffness as measured by baPWV in 434 postmeno‐
pausal women. The odds ratios (ORs) and 95% confidence intervals (95% CIs) for high 
baPWV were calculated after adjusting for confounding variables across TG/HDL 
ratio quartiles using multiple logistic regression analysis. The mean values of mean‐
ingful cardiometabolic variables increased with TG/HDL ratio quartiles. The adjusted 
baPWV (SEs) significantly increased with TG/HDL quartiles: Q1 = 1412 (22.1), 
Q2 = 1469 (21.4), Q3 = 1482 (21.0), and Q4 = 1505 (21.6) cm/s after adjusting for 
age, body mass index (BMI), and systolic blood pressure. The OR (95% CI) of the high‐
est TG/HDL ratio quartile as compared to the lowest TG/HDL ratio quartile for high 
PWV was 2.77 (1.16‐6.63) after adjusting for age, BMI, smoking status, regular exer‐
cise, mean arterial pressure, fasting plasma glucose, total cholesterol level, hyperten‐
sion, log‐transformed C‐reactive protein, and the use of antihypertensive and 
lipid‐lowering drugs. The TG/HDL ratio was positively and independently associated 
with arterial stiffness in postmenopausal Korean women.
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vascular changes that may lead to high TG with low HDL cholesterol 
and arterial stiffness.
Arterial stiffness is caused by structural and functional 
changes within the arterial walls, resulting in an increased pulse 
wave velocity (PWV). The PWV is a noninvasive and useful 
measure of arterial stiffness8,9 and is also a reliable indicator of 
vascular damage and early atherosclerosis.9 Increased arterial 
stiffness as measured by PWV has been reported as a significant 
predictor of cardiovascular events and mortality.10 Carotid‐fem‐
oral PWV (cfPWV), a measure of arterial PWV through the entire 
aorta, is the most recognized and established index of central 
arterial stiffness. However, from a practical point of view, cfPWV 
has some limitations, such as a long time for measurement, ex‐
aminer variability, and inconvenience of exposing the femoral 
site. Recently, a simple, automated device has become available 
to measure brachial‐ankle PWV (baPWV), an index of peripheral 
arterial stiffness, using a volume rendering method. Measuring 
baPWV is easier and more time‐effective than conventional mea‐
surement of cfPWV with a high correlation with cfPWV particu‐
larly in East Asian populations.11
Several epidemiological studies have reported that a high TG/
HDL ratio has a positive association with arterial stiffness in both 
adult and adolescent populations12,13; it is not known whether TG/
HDL ratio is related to baPWV in postmenopausal women. Thus, in 
this study, the authors aimed to investigate the association between 
TG/HDL ratio and arterial stiffness as measured by baPWV in post‐
menopausal women.
2  | METHODS
2.1 | Study participants
From January 1, 2015, through July 31, 2015, researchers retro‐
spectively reviewed the medical records of 615 postmenopausal 
women who voluntarily visited the health promotion center of 
Yonsei University Gangnam Severance Hospital in Seoul, South 
Korea, for regular healthcare checkups. Menopause was defined as 
having no menstrual periods for 12 consecutive months following a 
final menstrual period in the absence of a clear biological or physi‐
ological cause. We excluded participants who met at least one of 
the following criteria: a history of exogenous estrogen or tamoxifen 
therapy; a history of induced menopause due to bilateral oopho‐
rectomy, radiation, or drug use; a history of ischemic heart disease, 
stroke, or thyroid or hepatobiliary disease; an ankle‐brachial index 
<0.9;	 and	 C‐reactive	 protein	 (CRP)	 ≥10.0	mg/L,	 and	 those	 with	
missing data or those who did not fast for 12 hours prior to testing. 
Following these exclusions, 434 participants aged 46 years or older 
were included in the final analysis. Each participant provided in‐
formed consent. This study was conducted in accordance with the 
ethical principles of the Declaration of Helsinki and was approved 
by the institutional review board of Yonsei University College of 
Medicine, Seoul, Korea.
2.2 | Data collection
Each participant completed a questionnaire about her lifestyle 
and medical history. Self‐reported cigarette smoking, alcohol con‐
sumption, and physical activity characteristics were taken from the 
questionnaires. Smoking status was categorized as non‐smoker, 
ex‐smoker, and current smoker. Alcohol drinking was defined as 
alcohol	 consumption	≥two	 times	per	week.	Participants	were	also	
asked about the type and frequency of leisure‐time physical ac‐
tivity on a weekly basis. Regular exercise was defined as exercise 
≥three	 times	 per	week.	 Body	mass	 and	 height	were	measured	 to	
the nearest 0.1 kg and 0.1 cm, respectively, in light indoor clothing 
without shoes. Body mass index (BMI) was calculated as the weight 
in kilograms divided by the square of the height in meters (kg/m2). 
Systolic blood pressure (SBP) and diastolic blood pressure (DBP) 
were measured twice in the sitting position after at least 10 min‐
utes of rest using the patient's right arm with a standard mercury 
sphygmomanometer (Baumanometer; WA Baum Co Inc, Copiague, 
NY).	 Mean	 arterial	 pressure	 was	 calculated	 using	 the	 equation	
(SBP + 2 × DBP)/3. All blood samples were obtained from the ante‐
cubital vein after 12 hours overnight fast. Fasting plasma glucose, 
total cholesterol, triglyceride, and HDL cholesterol levels were 
measured by enzymatic methods using a Hitachi 7600 automated 
chemistry analyzer (Hitachi Co., Tokyo, Japan). High‐sensitivity CRP 
concentrations were measured using the Roche/Hitachi 912 System 
(Roche	 Diagnostics,	 Indianapolis,	 IN),	 a	 latex‐enhanced	 immuno‐
turbidimetric method with a lower limit of detection of 0.02 mg/L. 
Hypertension	was	defined	as	SBP	≥	140	mm	Hg,	DBP	≥	90	mm	Hg,	
or use of hypertension medication. Type 2 diabetes was defined 
as	a	 fasting	plasma	glucose	 level	≥126	mg/dL	or	a	use	of	diabetes	
medication.
2.3 | BaPWV measurement
An automatic waveform analyzer (model BP‐203RPE; Colin Medical 
Technology Corp., Komaki, Japan) was used to measure PWV. This 
instrument simultaneously records blood pressure, phonocardio‐
gram, electrocardiogram, and arterial blood pressure at both the left 
and right brachial arteries and ankles. Subjects were examined in 
the supine position after 10 minutes of bed rest. Electrocardiogram 
electrodes were placed on both wrists, and a microphone for the 
phonogram was placed on the left edge of the sternum. Pneumonic 
cuffs were wrapped around both the upper arms and ankles and con‐
nected to a plethysmographic sensor to determine the volume pulse 
waveform. Waveforms for the upper arm (brachial artery) and ankle 
(tibial artery) were stored for 10‐second sample times with auto‐
matic gain analysis and quality adjustment. An oscillometric pressure 
sensor was attached to the cuffs to measure blood pressure at the 
four extremities. The baPWVs were recorded using a semiconductor 
pressure sensor (1200 Hz sample acquisition frequency) and calcu‐
lated	using	the	equation	(La−Lb)/ΔTba. La and Lb were defined as the 
distance from the aortic valve to the elbow and to the ankle, respec‐
tively, and are expressed as follows: La = 0.2195 × height of subject 
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(cm)	−	2.0734	 and	 Lb	=	0.8129	×	height	 of	 subject	 (cm)	+	12.328.	
The time interval between the arm and ankle distance (ΔTba) was 
defined as the pulse transit time between the brachial and tibial ar‐
terial pressure waveforms. La and Lb were automatically estimated 
based on the subjects’ heights. The coefficients of variation for inter‐ 
and intra‐observer reproducibility were 7.4% and 5.8%, respectively.
2.4 | Statistical analysis
TG/HDL	ratio	quartiles	were	categorized	as	follows:	Q1:	≤1.11,	Q2:	
1.12‐1.66,	Q3:	1.67‐2.69,	and	Q4:	≥2.70.	The	clinical	characteristics	
of the study population according to TG/HDL ratio quartiles were 
compared	using	a	one‐way	analysis	of	variance	(ANOVA)	or	Kruskal‐
Wallis test for continuous variables according to the normality of dis‐
tributions and chi‐square test for categorical variables. Continuous 
data are presented as the mean (standard deviation, SD) or median 
(interquartile range, IQR), and categorical data are presented as 
the frequency. The mean differences between groups were deter‐
mined	using	post	hoc	analysis	of	ANOVA	test	using	Tukey	correc‐
tions. Pearson correlation coefficients (r) were calculated to assess 
associations between baPWV and triglyceride or HDL cholesterol. 
The adjusted mean values of baPWV were calculated using analysis 
of	covariance	(ANCOVA)	test	after	adjusting	for	age,	BMI,	and	SBP.	
The high baPWV was determined as more than 1600 cm/s, which 
corresponded to the 75th percentile of the current sample. The odds 
ratios (ORs) and 95% confidence intervals (95% CIs) for high baPWV 
were calculated after adjusting for confounding variables across TG/
HDL ratio quartiles using multiple logistic regression analysis. All 
analyses were conducted using the SAS statistical software (version 
9.4;	SAS	Institute	Inc,	Cary,	NC).	All	statistical	tests	were	two‐sided,	
and statistical significance was determined at P < 0.05.
3  | RESULTS
Table 1 shows the distribution of clinical characteristics across the 
TG/HDL ratio quartiles. The mean values of meaningful cardiometa‐
bolic variables, including age, BMI, blood pressure, and fasting plasma 
glucose levels, and the median CRP level increased proportionally 
with the TG/HDL ratio quartiles. The prevalence of hypertension 
TA B L E  1   Clinical characteristics of the study population according to TG/HDL ratio quartiles in postmenopausal women
TG/HDL ratio quartiles
P‐valuea Post hocTotal Q1 (≤1.11) Q2 (1.12‐1.66) Q3 (1.67‐2.69) Q4 (≥2.70)
n 434 107 110 106 111
Age (years) 58.3 (6.6) 56.3 (6.1) 58.4 (6.6) 58.3 (6.6) 60.2 (6.6) <0.001 c
Body mass index 
(kg/m2)
23.2 (3.0) 21.7 (2.3) 23.1 (3.3) 23.5 (3.0) 24.4 (2.8) <0.001 a, b, c, d
Systolic blood 
pressure (mm Hg)
124.9 (19.3) 118.9 (15.5) 123.7 (22.0) 125.4 (18.2) 131.6 (18.7) <0.001 c, e
Diastolic blood 
pressure (mm Hg)
76.2 (11.1) 73.3 (9.2) 74.9 (12.3) 76.2 (11.2) 80.3 (10.3) <0.001 c, e, f
Mean arterial 
pressure (mm Hg)
92.4 (13.4) 88.5 (11.0) 91.2 (15.0) 92.6 (13.1) 97.4 (12.7) <0.001 c, e, f
Fasting plasma 
glucose (mmol/L)
5.31 (0.99) 4.97 (0.74) 5.43 (1.01) 5.38 (0.94) 5.46 (1.18) <0.001 a, b, c
Total cholesterol 
(mmol/L)
5.25 (0.96) 5.21 (0.88) 5.15 (0.91) 5.38 (1.15) 5.27 (0.88) 0.348 ‐
C‐reactive protein 
(mg/L)
0.70 (0.34‐1.50) 0.41 (0.30‐0.90) 0.70 (0.30‐1.50) 0.80 (0.30‐1.50) 1.00 
(0.50‐2.08)
<0.001 ‐
Current smoking 
(%)
3.7 1.0 4.9 6.2 2.8 0.378 ‐
Alcohol drinking 
(%)b
11.8 13.7 11.1 12.1 10.4 0.899 ‐
Regular exercise 
(%)c
42.0 46.7 50.5 36.0 34.6 0.049 ‐
Hypertension (%) 59.4 28.9 40.0 40.6 59.5 <0.001 ‐
Type 2 diabetes (%) 7.1 3.7 8.2 8.5 8.1 0.476 ‐
Data are expressed as the mean (SD), median (IQR), or percentage.
aP‐values	were	calculated	using	1‐way	ANOVA	test,	Kruskal‐Wallis	test,	or	chi‐square	test.	
bAlcohol	drinking	≥twice/week.	
cRegular	exercise	≥three	times/week.	Post	hoc	analysis	of	ANOVA	test	for	mean	difference	between	groups:	a,	Q1	vs	Q2;	b,	Q1	vs	Q3,	c:	Q1	vs	Q4;	d,	
Q2 vs Q3; e, Q2 vs Q4, and f, Q3 vs Q4. 
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increased in accordance with the TG/HDL ratio quartiles. When ex‐
amined as continuous variables, baPWV was positively correlated 
with log‐transformed triglyceride (r = 0.218 P < 0.001) and inversely 
correlated with HDL cholesterol (r	=	−0.187,	 P = 0.004) (data not 
shown).
Figure 1 shows the age, BMI, and SBP adjusted means and SE 
of baPWV according to the TG/HDL ratio quartiles. The adjusted 
baPWV (SEs) significantly increased with the TG/HDL quartiles: 
Q1 = 1412 (22.1), Q2 = 1469 (21.4), Q3 = 1482 (21.0), and Q4 = 1505 
(21.6) cm/s.
Table 2 describes the ORs for high baPWV according to the TG/
HDL ratio quartile. The OR (95% CI) of the highest TG/HDL ratio 
quartile as compared to the lowest TG/HDL ratio quartile for high 
PWV was 2.77 (1.16‐6.63) after adjusting for age, BMI, smoking sta‐
tus, regular exercise, mean arterial pressure, fasting plasma glucose, 
total cholesterol level, hypertension, log‐transformed CRP, and the 
use of antihypertensive and lipid‐lowering drugs.
4  | DISCUSSION
In this cross‐sectional study, researchers found that the TG/HDL 
ratio was positively and independently associated with arterial stiff‐
ness in postmenopausal women. Our findings are consistent with the 
results of previous studies that demonstrated that a high TG/HDL 
ratio has positive associations with arterial stiffness in adult popu‐
lations.13,14 A high TG/HDL ratio was significantly associated with 
increased arterial stiffness as measured by the cardio‐ankle vascular 
index	(>8.0)	among	Japanese	diabetic	men	according	to	the	Nagasaki	
Island Study.14 In 1498, apparently healthy Chinese individuals (men 
n = 926 and women n = 572) participated in a routine health screen‐
ing program. Wen et al13 also found a similar positive relationship 
between the TG/HDL quartiles and high baPWV (>1400 cm/s) for 
both men and women. In a recent Japanese study, TG/HDL ratio was 
positively related with baPWV when the TG/HDL ratio was less than 
5.6 in 912 individuals, aged 24‐84 years, after adjusting for age, sex, 
and other potential confounding variables.15
This positive association between TG/HDL ratio and arterial 
stiffness as measured by cfPWV was also reported in adolescents 
and young adults, especially in obese youth among 894 children, ad‐
olescents, and young adults in the United States.12 Consistent with 
previous findings in adults and adolescents, we found that high TG/
HDL was significantly associated with increased arterial stiffness in 
postmenopausal women, suggesting that this positive association 
can be applied to all age‐groups.
Arterial stiffness is caused by structural and functional changes 
within the arterial walls, resulting in increased arterial stiffness. 
There are plausible mechanisms for the significant association be‐
tween the TG/HDL ratio and increased PWV in postmenopausal 
F I G U R E  1   Adjusted mean values 
of brachial‐ankle pulse wave velocity 
according to the TG/HDL ratio quartiles 
after adjusting for age, body mass index, 
and systolic blood pressure (bars mean 
standard errors, *P < 0.01, **P < 0.05)
TG/HDL ratio quartiles
Q1 (≤1.11) Q2 (1.12‐1.66) Q3 (1.67‐2.69) Q4 (≥2.70)
Model 1 1.00 (Reference) 2.27 (1.03‐5.05) 2.33 (1.04‐5.24) 3.98 (1.81‐8.77)
Model 2 1.00 (Reference) 1.94 (0.81‐4.63) 2.03 (0.86‐4.81) 2.84 (1.22‐6.64)
Model 3 1.00 (Reference) 1.68 (0.68‐4.13) 2.01 (0.83‐4.89) 2.77 (1.16‐6.63)
Model 1: adjusted for age, body mass index, and smoking status.
Model 2: adjusted for age, body mass index, smoking status, regular exercise, mean arterial pressure, 
fasting plasma glucose, total cholesterol level, and hypertension.
Model 3: adjusted for age, body mass index, smoking status, regular exercise, mean arterial pressure, 
fasting plasma glucose, total cholesterol level, hypertension, log‐transformed C‐reactive protein, 
and the use of antihypertensive and lipid lowering drugs.
TA B L E  2   Odds ratios and 95% 
confidence intervals for high pulse wave 
velocity according to TG/HDL ratio 
quartiles
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women. First, an increased TG/HDL ratio is closely associated with 
arterial stiffness linked to insulin resistance in postmenopausal 
women.16,17 A decrease in estrogen leads to an increase in abdomi‐
nal visceral fat mass, which stimulates an influx of free fatty acid to 
the liver and consequently influences lipid metabolism, especially in‐
creased TG and decreased HDL cholesterol levels in postmenopausal 
women.6,18 Additionally, advanced glycation end products, accom‐
panied by insulin resistance, generate reactive oxygen and nitrogen 
species, which stimulate binding of the glycated LDL cholesterol to 
the arterial intima and excessive LDL cholesterol accumulation in the 
arterial wall, subsequently triggering arterial stiffness.19,20 Second, 
TG/HDL and arterial stiffness may be linked by a low‐grade inflam‐
mation in the vessel wall. Chronic low‐grade inflammation plays a 
crucial role in initiating and propagating the atherosclerotic process. 
Stimulated leukocytes release a variety of cytokines and growth fac‐
tors and have an increased tendency to adhere to vascular endo‐
thelium and easily penetrate the intima, which can induce further 
vascular damage and increased vascular resistance.21 Indeed, in the 
present study, log‐transformed CRP levels gradually increased with 
increasing TG/HDL quartiles.
The following limitations should be considered in the interpre‐
tation of this study. First, because of the cross‐sectional design, 
caution should be used in causal and temporal interpretations; 
thus, it cannot be concluded whether the TG/HDL ratio is a risk 
factor actively involved in the development of arterial stiffness. 
Further prospective research is warranted to elucidate these pos‐
itive correlations between TG/HDL ratio and arterial stiffness. 
Second, since study participants were limited to those who vis‐
ited a single hospital for health promotion screening programs 
and appeared to be slightly healthier than most community‐based 
cohorts, the study population may not be representative of the 
general population. Third, self‐reporting of lifestyle data such as 
smoking, alcohol consumption, and physical activity may be an in‐
formation bias in this study because the answers from participants 
could be arbitrary and incomplete. Fourth, central obesity indi‐
cated by waist circumference or visceral fat mass is more likely to 
be associated with baPWV; however, waist circumference was not 
evaluated at the beginning of this study. Finally, arterial stiffness 
as baPWV was assessed instead of cfPWV in the present study. 
Conventionally, cfPWV has been considered an accuracy and gold 
standard measure of arterial stiffness.22 However, measurement 
of baPWV has been widely used particularly in East Asian pop‐
ulations and is easier and more time‐effective than conventional 
measurement of cfPWV. Tanaka et al11 reported a high correla‐
tion between baPWV and cfPWV (r = 0.73, P < 0.001) in 2287 
Japanese individuals. Despite these potential limitations, our 
study also has strengths. We believe that this is the first study to 
evaluate the association between serum TG/HDL ratio and arterial 
stiffness in apparently healthy postmenopausal women. Our study 
was designed to clarify the associations between serum TG/HDL 
ratio and arterial stiffness in postmenopausal women with natural 
menopause and arterial stiffness by excluding those with induced 
or secondary menopause and estrogen replacement therapy. Early 
and premature menopause women result of an abrupt loss of ovar‐
ian function or total hysterectomy has a higher risk of CVD than 
natural menopause women.23,24
5  | CONCLUSIONS
The TG/HDL ratio was positively and independently associated with 
arterial stiffness in postmenopausal Korean women. These findings 
suggest that the TG/HDL ratio, a simple, general, and economical 
biomarker, may be a useful surrogate indicator of arterial stiffness in 
postmenopausal Korean women.
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